Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan.
Wong CK, Lambert AW, Ozturk S, Papageorgis P, Lopez D, Shen N, Sen Z, Abdolmaleky HM, Győrffy B, Feng H, Thiagalingam S.
Wong CK, et al. Among authors: abdolmaleky hm.
Mol Cancer Res. 2020 Mar;18(3):414-423. doi: 10.1158/1541-7786.MCR-19-0525. Epub 2020 Jan 13.
Mol Cancer Res. 2020.
PMID: 31932471
Free PMC article.